155 related articles for article (PubMed ID: 14222727)
1. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
Encephale; 1964; 53():520-35. PubMed ID: 14222727
[No Abstract] [Full Text] [Related]
2. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
LUDWIG AM; LEVINE J
JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
[No Abstract] [Full Text] [Related]
3. [REVIEW OF PSYCHODYSLEPTICS: I. CLASSIFICATION OF PSYCHODYSLEPTICS].
RAJOTTE P
Can Med Assoc J; 1964 Aug; 91(6):293-300. PubMed ID: 14184040
[TBL] [Abstract][Full Text] [Related]
4. THE HALLUCINOGENIC DRUGS.
BARRON F; JARVIK ME; BUNNELL S
Sci Am; 1964 Apr; 210():29-37. PubMed ID: 14143391
[No Abstract] [Full Text] [Related]
5. Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Schneider C
Nature; 1968 Nov; 220(5167):586-7. PubMed ID: 5686733
[No Abstract] [Full Text] [Related]
6. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
CURTIS DR
Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
[No Abstract] [Full Text] [Related]
7. [USE OF PSYCHOTROPIC DRUGS IN PSYCHOTHERAPY].
STEVENIN L; BENOIT JC
Acta Psychother Psychosom; 1964; 12():168-87. PubMed ID: 14162290
[No Abstract] [Full Text] [Related]
8. A NEUROPHARMACOLOGICAL INVESTIGATION ON HALLUCINOGENIC DRUGS. LABORATORY RESULTS VERSUS CLINICAL TRIALS.
LONGO VG; BOVET D
Acta Neurochir (Wien); 1964; 12():215-29. PubMed ID: 14293377
[No Abstract] [Full Text] [Related]
9. [SEROTONIN AND PSYCHIATRY].
PELICIER Y
Pathol Biol; 1964 Nov; 12():1107-9. PubMed ID: 14224288
[No Abstract] [Full Text] [Related]
10. [COMPARATIVE STUDY OF TRYPTAMINE BLOCKING AGENTS].
BUENO JR; KURTZ GS; SOLLERO L
Hospital (Rio J); 1964 May; 65():1051-61. PubMed ID: 14172173
[No Abstract] [Full Text] [Related]
11. [PSYCHODYSLEPTIC DRUGS. II. SOME PROBLEMS RELATED TO THEIR USE].
RAJOTTE P
Can Med Assoc J; 1964 Aug; 91(7):335-42. PubMed ID: 14184041
[TBL] [Abstract][Full Text] [Related]
12. EFFECT OF CENTRALLY-ACTING DRUGS ON MOBILIZATION OF FREE FATTY ACIDS.
HOLLISTER LE
Arch Int Pharmacodyn Ther; 1964 Jun; 149():362-5. PubMed ID: 14191070
[No Abstract] [Full Text] [Related]
13. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
GERSHON S; OLARIU J
J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
[No Abstract] [Full Text] [Related]
14. Analysis of hallucinogenic drugs.
Sperling A
J Chromatogr Sci; 1972 May; 10(5):268-75. PubMed ID: 4561542
[No Abstract] [Full Text] [Related]
15. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.
HARTMAN AM; HOLLISTER LE
Psychopharmacologia; 1963 Aug; 4():441-51. PubMed ID: 14048565
[No Abstract] [Full Text] [Related]
16. 'Hallucinogenic drugs and central transmitter substances'.
Leonard BE
Int J Neurosci; 1972 Jul; 4(1):35-43. PubMed ID: 4348844
[No Abstract] [Full Text] [Related]
17. THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA.
KEELER MH
N C Med J; 1963 Dec; 24():555-7. PubMed ID: 14089896
[No Abstract] [Full Text] [Related]
18. FACTORS MODIFYING CHLORPROMAZINE HYPERTHERMIA IN YOUNG ALBINO MICE.
BAGDON WJ; MANN DE
J Pharm Sci; 1965 Feb; 54():240-6. PubMed ID: 14293811
[No Abstract] [Full Text] [Related]
19. [PHARMACOLOGICAL CHARACTERIZATION AND DETECTION OF HALLUCINOGENIC SUBSTANCES. I. HYPERTHERMIC ACTION IN THE RABBIT].
JACOB J; LAFILLE C
Arch Int Pharmacodyn Ther; 1963 Oct; 145():528-45. PubMed ID: 14067574
[No Abstract] [Full Text] [Related]
20. [STUDIES WITH CENTRALLY ACTING ANTICHOLINERGICS].
HOFFMEISTER F; KREISKOTT H; WIRTH W
Arzneimittelforschung; 1964 Jun; 14():SUPPL:482-6. PubMed ID: 14253943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
